top of page
![](https://static.wixstatic.com/media/dd07f1_7df5b1ec3d804078b9f0cfd766fdbd39~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/dd07f1_7df5b1ec3d804078b9f0cfd766fdbd39~mv2.webp)
![Novartis celebrates Canada-wide implementation of newborn screening for spinal muscular atrophy](https://static.wixstatic.com/media/dd07f1_7df5b1ec3d804078b9f0cfd766fdbd39~mv2.jpg/v1/fill/w_514,h_386,fp_0.50_0.50,q_90,enc_auto/dd07f1_7df5b1ec3d804078b9f0cfd766fdbd39~mv2.webp)
Aug 20, 20242 min read
Novartis celebrates Canada-wide implementation of newborn screening for spinal muscular atrophy
Novartis applauds Muscular Dystrophy Canada to ensure that every newborn in Canada will be screened to detect spinal muscular atrophy (SMA).
bottom of page